HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-liang Gan Selected Research

Cromolyn Sodium (Cromoglicic Acid)

10/2012[Effects of cromolyn sodium on intestinal ischemia-reperfusion injury by inhibiting PAR-2 expression in rats].
9/2008Influence of Ketotifen, Cromolyn Sodium, and Compound 48/80 on the survival rates after intestinal ischemia reperfusion injury in rats.
9/2008Influence of cromolyn sodium and compound 48/80 administered prior to and after reperfusion on the third day's survival rate in a rat intestinal ischemia model.
5/2007[Cromolyn sodium ameliorates rat left cardiac function during intestinal ischemia-reperfusion].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-liang Gan Research Topics

Disease

3Reperfusion Injury
10/2012 - 05/2007
3Ischemia
10/2012 - 05/2007
1Hypoxia (Hypoxemia)
10/2009
1Hepatopulmonary Syndrome
10/2009
1Hemorrhagic Shock
11/2006
1Liver Cirrhosis (Hepatic Cirrhosis)
07/2006
1Hepatitis B
10/2005

Drug/Important Bio-Agent (IBA)

4Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric
10/2012 - 05/2007
3p-Methoxy-N-methylphenethylamineIBA
10/2012 - 09/2008
1PAR-2 ReceptorIBA
10/2012
1Mast Cell StabilizersIBA
10/2012
1salicylhydroxamic acid (SHAM)IBA
10/2012
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2009
1Endothelin-1 (Endothelin 1)IBA
10/2009
1Ketotifen (Ketotifene)FDA Link
09/2008
1AntioxidantsIBA
11/2006
1Oxygen (Dioxygen)IBA
10/2005

Therapy/Procedure

2Liver Transplantation
10/2009 - 10/2005
1General Anesthesia
07/2006